ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "cytokines"

  • Abstract Number: 486 • 2016 ACR/ARHP Annual Meeting

    IRF5 Promotes Arthritis but Restricts Virus Replication and Spread during Chikungunya Virus Infection

    Jonathan Miner1, Amber Smith2, Raeann Shimak2 and Michael Diamond3, 1Internal Medicine / Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, 2Washington University in Saint Louis School of Medicine, Saint Louis, MO, 3Medicine / Infectious Diseases, Washington University in Saint Louis School of Medicine, Saint Louis, MO

    Background/Purpose: Chikungunya virus (CHIKV) is an arthritogenic alphavirus that invades the joints and causes chronic arthritis in up to 60% of infected individuals. Over the…
  • Abstract Number: 1658 • 2016 ACR/ARHP Annual Meeting

    Regulatory Role of  the IL-9/IL-9R System  on Pannus Formation in Psoriatic Arthritis

    Siba P. Raychaudhuri1,2 and Smriti K. Raychaudhuri3, 1Davis, CA, 2Rheumatology, Univ of California, Davis & VAMC Sacramento, Davis, CA, 3Rheumatology/Immunology, VA Sacramento Medical Center, Davis, CA

        Background/Purpose:  Earlier we have reported that synovial tissues of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) are enriched with the Th9 cells along…
  • Abstract Number: 3006 • 2016 ACR/ARHP Annual Meeting

    IFN-Gamma (IFNγ), IFNγ-Induced Chemokines and Other Biomarkers in Macrophage Activation Syndrome (MAS)

    Claudia Bracaglia1, Denise Pires Marafon2, Ivan Caiello2, Kathy de Graaf3, Florence Guilhot3, Walter Ferlin3, Sergio Davì4, Grant Schulert5, Angelo Ravelli4, Alexei Grom6, Robert Nelson3, Cristina de Min3 and Fabrizio De Benedetti1, 1Division of Rheumatology, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy, Rome, Italy, 2Division of Rheumatology, Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Italy, 3NovImmune S.A., Geneva, Switzerland, 4Istituto Giannina Gaslini, Genoa, Italy, 5Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose:  Evidence in animals and humans points to a pivotal role of IFNγ in primary HLH. We have recently generated data in an animal model…
  • Abstract Number: 583 • 2016 ACR/ARHP Annual Meeting

    Associations of Serum Anti-Citrullinated Proteins and Cytokines with Radiographic Scores in African-American Rheumatoid Arthritis Patients

    Dongmei Sun1, William H Robinson2, Xiangqin Cui3, Vincent A. Laufer4, Maria I. Danila5, Richard J. Reynolds6, Chander Raman7, Stephanie Ledbetter8, Alexander Szalai9 and S. Louis Bridges Jr.9, 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 4Division of Clinical Rheumatology and Immunology, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Birmingham, AL, 6Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Medicine/Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 81825 University Blvd., University of Alabama at Birmingham, Birmingham, AL, 9Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Serum anti-citrullinated proteins (ACPA, including anti-CCP antibodies) and rheumatoid factor (RF) are critical diagnostic markers for RA, and are associated with more severe radiographic…
  • Abstract Number: 1824 • 2016 ACR/ARHP Annual Meeting

    Mycophenolate Mofetil Use Associates with Unique Biologic Changes in B Cell and T Regulatory Cell Pathways in SLE Patients

    Samantha Slight-Webb1, Rufei Lu2, Krista M. Bean1, Holden T. Maecker3, Paul J. Utz4, Joel M. Guthridge5 and Judith A. James6, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Medicine, Stanford University School of Medicine, Stanford, CA, 5Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose:  The management of systemic lupus erythematosus (SLE) is complicated by a heterogeneous clinical presentation. Currently, mycophenolate mofetil (MMF) is a commonly used medication to…
  • Abstract Number: 3107 • 2016 ACR/ARHP Annual Meeting

    Switching from Anabolic to Catabolic Metabolism – a Novel Immunomodulatory Therapy in RA

    Zhen Yang1, Yi Shen1, Eric L. Matteson2, Ebru Hosgur1, Jison Hong3, Jorg Goronzy4 and Cornelia M. Weyand1, 1Medicine: Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 2Rheumatology, Mayo Clinic, Rochester, MN, 3Medicine/Immunology & Rheumatology, Stanford University, Palo Alto, CA, 4Medicine/Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA

    Background/Purpose:  Inflammatory activity in RA relies on numerous anabolic processes; including cellular proliferation, cell trafficking, secretion of proinflammatory cytokines and release of antibodies. Lasting reversal…
  • Abstract Number: 633 • 2016 ACR/ARHP Annual Meeting

    High Similarity Between Ex-Vivo Inhibited Cytokine Profiling By Golimumab and Adalimumab As a Putative Explanation for Inferior Treatment Response to Golimumab after Adalimumab Failure in Rheumatoid Arthritis

    L. Tweehuysen1, K. Schraa2, M.G. Netea3, F.H.J. van den Hoogen4,5, L.A.B. Joosten3 and A.A. den Broeder4, 1Sint Maartenskliniek, Nijmegen, Netherlands, 2Internal Medicine, Radboudumc, Nijmegen, Netherlands, 3Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands, 4Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 5Rheumatology, Radboudumc, Nijmegen, Netherlands

    Background/Purpose: Better prediction of treatment response to biologics in rheumatoid arthritis (RA) would contribute to optimal individualized treatment. Clinical data suggest that the response of…
  • Abstract Number: 1862 • 2016 ACR/ARHP Annual Meeting

    Modelling Healthy and Scleroderma Fibrotic Skin in Vitro: Mechanical Stress Alters Macrophage Cytokine Expression and Triggers Signalling Via the Mechano-Sensing Transcription Factor Myocardin-Related Transcription Factor-a

    Angela Tam1, Shiwen Xu1, Henry Lopez1, Korsa Khan2, Bahja Ahmed Abdi3, Henrique Rosario4, Nikita Arumalla2, Mark Gibson2, Christopher Denton2, David Abraham2, Barbara D Smith5 and Richard J Stratton2, 1Division of Medicine, ​Centre for Rheumatology and Connective tissue disease, University College London, London, United Kingdom, 2Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 3Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 4Division of Medicine, Centre of Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 5Boston University School of Medicine, Boston, MA

    Background/Purpose: Skin involvement is one of the most prominent clinical features in scleroderma. There is a marked contrast in mechanical stiffness between healthy forearm skin…
  • Abstract Number: 690 • 2016 ACR/ARHP Annual Meeting

    Increase in Serum Leptin Levels Is Associated with Radiographic Progression of Male Patients with Ankylosing Spondylitis: A 2-Year Longitudinal Study

    Seung-Geun Lee1, Eun-Kyoung Park2, Ji-Heh Park1, Hee-Sang Tag3 and Geun-Tae Kim4, 1Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea, The Republic of, 3Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea, 4Kosin University College of Medicine, Busan, South Korea

    Background/Purpose:  The immunomodulatory effects of adipokines have been extensively studied in rheumatic diseases, there is a paucity of information regarding their effects on bone metabolism.…
  • Abstract Number: 1881 • 2016 ACR/ARHP Annual Meeting

    Targeting Oncostatin M in the Target Tissue: Assessment of in-Vivo Affinity and Target Engagement of an Anti-OSM Monoclonal Antibody By Combining Blood and Skin Blister Fluid Data

    Juliet Reid1, Stefano Zamuner2, Ken Edwards3, Sally Rumley4, Katherine Sully5, Maria Feeney6, Subramanya Kumar7, Disala Fernando7 and Nicolas Wisniacki1, 1ImmunoImflammation, GlaxoSmithKline, Stevenage, United Kingdom, 2Clinical Pharmacology, GlaxoSmithKline, Stevenage, United Kingdom, 3Statistics, GlaxoSmithKline, Stevenage, United Kingdom, 4Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, United Kingdom, 5Biopharm Translational Medicine, GlaxoSmithKline, Stevenage, United Kingdom, 6Biopharm Research, GlaxoSmithKline, Stevenage, United Kingdom, 7Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, United Kingdom

    Background/Purpose: Oncostatin M (OSM) is a pleiotropic member of the gp130/IL-6 cytokine family involved in pathological processes of fibrosis, inflammation and vasculopathy. Diffuse cutaneous systemic…
  • Abstract Number: 923 • 2016 ACR/ARHP Annual Meeting

    Retinoic Acid Inhibits Expression of Interleukin 9 By Altering Enhancer Architecture

    Daniella Schwartz1, Francoise Meylan2, Hong-Wei Sun3, Han-Yu Shih4, Kan Jiang4, Franziska Petermann4, Richard M. Siegel5, Arian Laurence6 and John J O'Shea7, 1NIAMS - Rheumatology, National Institutes of Health, Bethesda, MD, 2NIAMS, NIH, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4NIAMS, Rheumatology, National Institutes of Health, Bethesda, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 6University of Oxford, Oxford, United Kingdom, 7NIAMS NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD

    Background/Purpose: Vitamin A and its major metabolite, retinoic acid (ATRA), modulate T cell function and fitness to shape immune responses. Vitamin A deficiency causes increased…
  • Abstract Number: 1919 • 2016 ACR/ARHP Annual Meeting

    Analysis of T Cell Repertoire Diversity of CD4+ Memory and NaïVe T Cells By Next Generation Sequencing and Its Association with Rheumatoid Arthritis Disease Parameters

    Keiichi Sakurai1, Hirofumi Shoda1, Kazuyoshi Ishigaki2, Yumi Tsuchida1, Yasuo Nagafuchi1, Shuji Sumitomo1, Akari Suzuki2, Keishi Fujio1 and Kazuhiko Yamamoto1, 1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan

    Background/Purpose:  Rheumatoid arthritis (RA) is an autoimmune disease characterized by peripheral polyarthritis. The importance of CD4+ T cell in the pathophysiology of RA is well-known…
  • Abstract Number: 926 • 2016 ACR/ARHP Annual Meeting

    Increased Concentration of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Predate Onset of Rheumatoid Arthritis

    Linda Johansson1, Lisbeth Ärlestig1, Heidi Kokkonen2 and Solbritt Rantapaa-Dahlqvist3, 1Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 2Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden, 3Umeå University, Department of Public Health and Clinical Medicine/ Rheumatology, Umeå, Sweden

    Background/Purpose:  Receptor activator of nuclear factor κB ligand (RANKL) an important regulator of bone metabolism has a key role in local bone destruction and osteoporosis…
  • Abstract Number: 1989 • 2016 ACR/ARHP Annual Meeting

    Mechanism of STAT3 Gain-of-Function in a Patient with JIA

    Tiphanie P. Vogel1,2, Nermina Saucier3, Molly P. Keppel3 and Megan A. Cooper3,4, 1Pediatrics/Rheumatology, Washington University in St. Louis, St. Louis, MO, 2Internal Medicine/Rheumatology, Washington University in St. Louis, Saint Louis, MO, 3Pediatrics/Rheumatology, Washington University in St. Louis, Saint Louis, MO, 4Pathology and Immunology, Washington University in St. Louis, Saint Louis, MO

    Background/Purpose:  The transcription factor signal transducer and activator of transcription 3 (STAT3) mediates cytokine-induced changes in gene expression. STAT3 is classically activated by phosphorylation followed…
  • Abstract Number: 1096 • 2016 ACR/ARHP Annual Meeting

    Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes

    Satoshi Yamasaki1, Yusuke Yoshida2 and Eiji Sugiyama2, 1Hiroshima University Hospital, Hiroshima, Japan, 2Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

    Background/Purpose: Wnt family proteins canonically stabilize β-catenin to activate T-cell factor (TCF) for the transcription of several genes, including Runx2, which is important for osteoblastogenesis.…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 42
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology